サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1539629

体外診断（IVD）検査におけるバイオインフォマティクスの世界市場レポート 2024年

Bioinformatics In In-Vitro Diagnostics (IVD) Testing Global Market Report 2024
出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.47円
体外診断（IVD）検査におけるバイオインフォマティクスの世界市場レポート 2024年
出版日: 2024年08月21日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

体外診断（IVD）検査におけるバイオインフォマティクスの市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.9%で1,215億7,000万米ドルに成長します。予測期間の成長は、疾病の蔓延の増加、ヘルスケアにおけるITの統合、政府の取り組みと資金提供、個別化医療へのシフト、診断におけるバイオインフォマティクスの利点に関する医療従事者の意識の高まり、ゲノム配列決定のコスト低下などに起因すると考えられます。予測期間における主な動向には、人工知能（AI）と機械学習、次世代シーケンシング、ポイントオブケア（POC）検査、クラウドコンピューティングとビッグデータ、免疫化学技術の進歩などがあります。

がんの罹患率の上昇は、体外診断（IVD）検査におけるバイオインフォマティクス市場の成長を促進すると予想されます。がんには、全身に広がる可能性のある異常な細胞増殖を特徴とする様々な疾患が含まれます。被曝、ライフスタイルの選択、環境の影響などの要因が、その罹患率の増加に寄与しています。がん診断の分野では、IVD検査におけるバイオインフォマティクスは、早期発見、治療決定、患者の転帰を改善する正確で個別化された遺伝学的洞察を提供することにより、重要な役割を果たしています。例えば2021年5月、国立医学図書館によると、世界のがん罹患数は2040年までに2,840万人に達し、2020年から47%増加すると予測されています。このようながん罹患率の上昇傾向は、体外診断（IVD）検査におけるバイオインフォマティクスの重要な促進要因となっています。

この市場の大手企業は、技術革新、特に次世代シーケンス（NGS）技術に注力しています。NGSは、ゲノム全体または特定のDNA・RNA領域の迅速なシーケンシングを可能にし、包括的な遺伝子解析を容易にします。例えば、2022年5月、イルミナ・インクはCEマークを取得したTruSight Oncology Comprehensive（EU）検査に汎がんコンパニオン診断（CDx）適応を導入しました。この検査は、神経栄養型チロシン受容体キナーゼ（NTRK）遺伝子融合（NTRK1、NTRK2、またはNTRK3）を保有する固形がん患者で、バイエル薬品のVitrakvi（ラロトレクチニブ）による標的治療が有効な可能性のある患者を同定します。TSO Comprehensive（EU）検査は、次世代シーケンサーを用いた包括的ゲノム・プロファイリング（CGP）を採用しており、1つの生検検体から複数の腫瘍遺伝子とバイオマーカーを解析することで、各患者固有のがん分子プロファイルを決定します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場の実績：規模と成長, 2018-2023
  • 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場の予測：規模と成長, 2023-2028, 2033年

第6章 市場セグメンテーション

  • 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：タイプ別、実績と予測, 2018-2023, 2023-2028年, 2033年
  • ハードウェア
  • ソフトウェア
  • 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場テストの種類別、実績と予測, 2018-2023, 2023-2028年, 2033年
  • 血液検査
  • 組織ベースの検査
  • 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：用途別、実績と予測, 2018-2023, 2023-2028年, 2033年
  • 心血管疾患
  • 慢性疾患
  • 糖尿病
  • がん
  • その他の用途

第7章 地域別・国別分析

  • 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：地域別、実績と予測, 2018-2023, 2023-2028年, 2033年
  • 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：国別、実績と予測, 2018-2023, 2023-2028年, 2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 体外診断（IVD）検査におけるバイオインフォマティクス市場：競合情勢
  • 体外診断（IVD）検査におけるバイオインフォマティクス市場：企業プロファイル
    • Siemens Healthineers
    • International Business Machines Corporation
    • Medtronic Inc.
    • Parker Hannifin Corp.
    • Illumina Inc

第31章 その他の大手企業と革新的企業

  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Kollmorgen Corp
  • Bioreference Laboratories Inc.
  • AssureRx Health Inc.
  • Biodesix Inc.
  • Crescendo Bioscience Inc.
  • Affymetrix
  • Complete Genomics Inc.
  • Aperico Technologies Inc.
  • One Lambda Inc.
  • Datech Oncology
  • Life Technologies
  • Signal genetics
  • CardioDx Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r19068

Bioinformatics in in vitro diagnostics (IVD) involves applying computational methods, data analysis, and software tools to interpret biological data from diagnostic tests conducted outside the living organism. This includes using algorithms and statistical models to process large volumes of molecular and clinical data.

In the realm of bioinformatics in IVD testing, hardware encompasses the physical components and devices used in laboratory and computational settings. These tests, which include blood-based and tissue-based assays, find applications in detecting conditions such as cardiovascular diseases, chronic illnesses, diabetes, cancer, among others.

The bioinformatics in IVD testing market research report is one of a series of new reports from The Business Research Company that provides bioinformatics in IVD testing market statistics, including bioinformatics in IVD testing industry global market size, regional shares, competitors with bioinformatics in IVD testing market share, detailed bioinformatics in IVD testing market segments, market trends, and opportunities, and any further data you may need to thrive in the bioinformatics in IVD testing industry. This bioinformatics in IVD testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioinformatics in in vitro diagnostics (IVD) testing market size has grown strongly in recent years. It will grow from $87.25 billion in 2023 to $93.02 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The increase during the historical period can be credited to enhancements in healthcare infrastructure, expansion of biobanks, a growing elderly population, government initiatives and funding, and the advancement of personalized medicine.

The bioinformatics in in vitro diagnostics (IVD) testing market size is expected to see strong growth in the next few years. It will grow to $121.57 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing disease prevalence, integration of IT in healthcare, government initiatives and funding, the shift towards personalized medicine, heightened awareness among healthcare providers about the benefits of bioinformatics in diagnostics, and declining costs of genomic sequencing. Key trends in the forecast period include artificial intelligence (AI) and machine learning, next-generation sequencing, point-of-care (POC) testing, cloud computing and big data, and advancements in immunochemical techniques.

The rising incidence of cancer is expected to drive growth in the bioinformatics in IVD testing market. Cancer encompasses various diseases characterized by abnormal cell growth that can spread throughout the body. Factors such as exposure, lifestyle choices, and environmental influences contribute to its increasing prevalence. In the field of cancer diagnostics, bioinformatics in IVD testing plays a crucial role by offering precise, personalized genetic insights that improve early detection, treatment decisions, and patient outcomes. For instance in May 2021, according to the National Library of Medicine, global cancer cases are projected to reach 28.4 million by 2040, marking a 47% increase from 2020. This upward trend in cancer incidence is a key driver for the bioinformatics in the IVD testing market.

Leading companies in this market are focused on innovation, particularly in next-generation sequencing (NGS) technology. NGS enables rapid sequencing of entire genomes or specific DNA and RNA regions, facilitating comprehensive genetic analysis. For example, in May 2022, Illumina Inc. introduced a pan-cancer companion diagnostic (CDx) indication for its CE-marked TruSight Oncology Comprehensive (EU) test. This test identifies cancer patients with solid tumors harboring neurotrophic tyrosine receptor kinase (NTRK) gene fusions (NTRK1, NTRK2, or NTRK3), who may benefit from targeted therapy with Bayer's Vitrakvi (larotrectinib). The TSO Comprehensive (EU) test employs comprehensive genomic profiling (CGP), using next-generation sequencing to analyze multiple tumor genes and biomarkers from a single biopsy specimen, thereby determining each patient's specific cancer molecular profile.

In August 2021, Illumina Inc., a US-based company specializing in manufacturing integrated systems for genetic variation and biological function analysis, acquired GRAIL for an undisclosed sum. This acquisition is intended to accelerate patient access to diagnostic tools capable of detecting multiple types of cancer from a single blood sample. GRAIL, also based in the US, specializes in bioinformatics for in vitro diagnostic (IVD) testing.

Major companies operating in the bioinformatics in in-vitro diagnostics (IVD) testing market are Siemens Healthineers, International Business Machines Corporation, Medtronic Inc., Parker Hannifin Corp., Illumina Inc, PerkinElmer Inc., QIAGEN N.V., Kollmorgen Corp, Bioreference Laboratories Inc., AssureRx Health Inc., Biodesix Inc., Crescendo Bioscience Inc., Affymetrix, Complete Genomics Inc., Aperico Technologies Inc., One Lambda Inc., Datech Oncology, Life Technologies, Signal genetics, CardioDx Inc.

North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioinformatics in in-vitro diagnostics (IVD) testing market consists of revenues earned by entities by providing services such as clinical decision support systems, sequence analysis, and clinical genomics software. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioinformatics in in vitro diagnostics (IVD) testing market also includes sales of sequencing tools and diagnostics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioinformatics In In-Vitro Diagnostics (IVD) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioinformatics in in-vitro diagnostics (IVD) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioinformatics in in-vitro diagnostics (IVD) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioinformatics in in-vitro diagnostics (IVD) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Hardware; Software
  • 2) By Type Of Test: Blood Based Tests; Tissue Based Tests
  • 3) By Application: Cardiovascular Diseases; Chronic Diseases; Diabetes; Cancer; Other Applications
  • Companies Mentioned: Siemens Healthineers; International Business Machines Corporation; Medtronic Inc.; Parker Hannifin Corp.; Illumina Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Characteristics

3. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Trends And Strategies

4. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Size and Growth

  • 5.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Segmentation

  • 6.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hardware
  • Software
  • 6.2. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood Based Tests
  • Tissue Based Tests
  • 6.3. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular Diseases
  • Chronic Diseases
  • Diabetes
  • Cancer
  • Other Applications

7. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Regional And Country Analysis

  • 7.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 8.1. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 9.1. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 9.2. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 10.1. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 11.1. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 11.2. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 12.1. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 13.1. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 14.1. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 14.2. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 15.1. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 15.2. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 16.1. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 17.1. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 18.1. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 19.1. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 20.1. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 21.1. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 21.2. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 22.1. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 23.1. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 23.2. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 24.1. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 24.2. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 25.1. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 25.2. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 26.1. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 26.2. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 27.1. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 28.1. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 28.2. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

  • 29.1. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
  • 29.2. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Landscape
  • 30.2. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Company Profiles
    • 30.2.1. Siemens Healthineers
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. International Business Machines Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Parker Hannifin Corp.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Illumina Inc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. Kollmorgen Corp
  • 31.4. Bioreference Laboratories Inc.
  • 31.5. AssureRx Health Inc.
  • 31.6. Biodesix Inc.
  • 31.7. Crescendo Bioscience Inc.
  • 31.8. Affymetrix
  • 31.9. Complete Genomics Inc.
  • 31.10. Aperico Technologies Inc.
  • 31.11. One Lambda Inc.
  • 31.12. Datech Oncology
  • 31.13. Life Technologies
  • 31.14. Signal genetics
  • 31.15. CardioDx Inc.

32. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Benchmarking

33. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

35. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Future Outlook and Potential Analysis

  • 35.1 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer